While more companies are using real-world data (RWD) and real-world evidence (RWE) in research, there are still barriers that ...

VESPER-1 and interim VESPER-3 data release expected in September 2025; Phase 3 initiation on track for late 2025 MET-233i (once-monthly amylin analog) delivered class-leading Phase 1 results including ...

AbCellera's AI-driven drug discovery model hasn't translated into meaningful growth. Click here to read an analysis of ABCL ...

Promising US data and strong sales growth in Q2 Second quarter 2025Net sales for the quarter totalled MSEK 49.8 (41.1), equivalent to an increase of 21% compared to the corresponding quarter 2024. At ...

Background The evidence on associations between ultra-processed foods (UPF) and lung cancer risk is limited and inconsistent.

Objective Radiotherapy (RT) can cause a range of negative impacts in addition to the intended treatment impacts. Pulmonary rehabilitation (PR) may improve the physical and psychological conditions of ...

VESPER-1 and interim VESPER-3 data release expected in September 2025; Phase 3 initiation on track for late 2025 MET-233i (once-monthly amylin analog) delivered ...

In the real world, ordering medical tests costs money, so Microsoft tracked the tests that the AI system and human doctors ordered to see which method could get it done more cheaply. Not only did ...

Restriction to randomised controlled trials may limit applicability to non-randomised ... Figure 1 shows the PRISMA flow diagram of the literature selection in this study. Actual screening numbers ...

In July 2025, Vertex Pharmaceuticals Incorporated conducted a study is to evaluate the pharmacokinetics, safety, tolerability ...

The drastic cost-cutting move follows the deaths of two teenagers that forced the company to restrict usage of its gene ...

Some of the most interesting data are precisely those illustrating the reality of clinical practice of physicians attending ...